Elev8 Brands, Inc. Signs New Manufacturing Agreement with Canbiola, Inc.
October 22 2018 - 08:30AM
InvestorsHub NewsWire
Elev8 Brands, Inc. Signs New
Manufacturing Agreement with Canbiola, Inc.
Elev8 Brands, Inc. Expands Product
Line
ORLANDO, FL
-- October 22, 2018 -- InvestorsHub NewsWire -- Elev8 Brands,
Inc. (OTCQB:
VATE), a holding company focused on the commercial development
of hemp and CBD-based products including hemp coffee, hemp tea,
hemp Cold Brew, CBD salve, CBD Lotions and CBD Tinctures that
target the health and wellness markets, is pleased to announce it
has signed a manufacturing and supply agreement with Canbiola, Inc.
(OTC
Pink: CANB) the Master Distributor for Pure Health Products,
LLC for the manufacturing of its new Zoe CBD
CryoGel.
This all new
CryoGel is an all-natural gel that not only helps to relieve pain,
but is also Vegan, Non-GMO, Non-GE, and made with all-natural and
organic components. This product is a fast-acting all-natural CBD
CryoGel infuses 99.9% pure CBD.
Elev8 Brands,
Inc.’s CEO, Ryan Medico, stated, “I have had some great
conversations with Canbiola CEO, Marco Alfonsi. We share in the
same passions and look forward to developing a deeper working
relationship.”
Marco Alfonsi,
CEO of Canbiola, said, “Canbiola is a company that is passionate
about improving people’s lives through bringing the highest quality
lab tested products to market with all-natural ingredients. With
Elev8 Brands, Inc. and Canbiola having many synergies, it makes
sense to work together for the expansion of our products and
respective brands.”
Medico
concluded, “This is a very exciting time in the world of hemp and
CBD. Finding opportunities to grow and work together is key.
Canbiola is a Company that we can expand our product line with
knowing they provide some of the highest quality CBD
around.”
About Elev8
Brands, Inc.:
Elev8 Brands,
Inc. specializes in the development and marketing of products for
the fitness and wellness markets. The company is founded based on
creating high-quality, sustainable, products for health- conscious
consumers.
About Elev8 Hemp
LLC:
Elev8 Hemp
LLC is a wholly-owned subsidiary of Elev8 Brands, Inc. which
focuses on the development and marketing of hemp-based food,
beverage, and health care products including hemp coffee and hemp
tea.
About 02 Breathe
LLC:
02 Breathe is
a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on
their oxygen bar while bringing in an array of CBD products. O2
Breathe carries CBD tinctures, CBD vape, CBD lotions and massage
products. 02 Breathe is currently looking to offer CBD at their
oxygen bar.
About Zoe CBD
LLC:
Zoe CBD is a
wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on the
development and marketing of CBD-based products such as CBD
Tinctures, CBD E-Juice, CBD Lotion and CBD Salve. Please visit,
http://www.zoecbd.com for more
information
www.facebook.com/elev8hemp www.instagram.com/elev8hemp www.twitter.com/elev8hemp www.02breathe.com
www.elev8hemp.com
About Canbiola,
Inc.
Canbiola, Inc. is a public
company trading under symbol
CANB.
Canbiola, Inc. is a US Company
embarking in the sale of a variety of Cannabidiol (CBD) based
products. Canbiola is in the process of developing its own line of
proprietary products as well as seeking synergistic value through
acquisitions in the CBD and the medical cannabis industry. Cannabis
is currently federally illegal and has legalized for medical
purposes in some form in a limited number of states. The company
has already launched several products found
at www.canbiola.com.
Follow us on Twitter and Facebook
Safe Harbor
Statement:
The information posted in this release may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. You can identify
these statements by use of the words "may," "will," "should,"
"plans," "expects," "anticipates," "continue," "estimate,"
"project," "intend," and similar expressions. Forward-looking
statements involve risks and uncertainties that could cause actual
results to differ materially from those projected or anticipated.
These risks and uncertainties include, but are not limited to,
general economic and business conditions, effects of continued
geopolitical unrest and regional conflicts, competition, changes in
technology and methods of marketing, delays in completing various
engineering and manufacturing programs, changes in customer order
patterns, changes in product mix, continued success in
technological advances and delivering technological innovations,
shortages in components, production delays due to performance
quality issues with outsourced components, and various other
factors beyond the Company's control.